InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,754.96
(
0.04%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

investor maven

Send PM Follow Ignore
Followers 5
Posts 487
Boards Moderated 0
Alias Born 10/15/2013

investor maven

Re: vidpok45 post# 77025

Tuesday, 10/04/2016 10:12:12 PM

Tuesday, October 04, 2016 10:12:12 PM

Post# of 80490
True, I have read comments (not from clinical data reports) that patients on the other drug spend a lot of their time actively nauseous and vomiting, while the emetic side effects of brigatinib are much more tolerable - leading most likely (based on prior similar examples) to better compliance and longer use of the drug. This will lead to better outcomes while maintaining a better quality of life.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up